XML 36 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Segment Data
12 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
1
5
. Segment Data
 
As of
March 31, 2016,
our
four
operating segments were Biological Indicators, Instruments, Continuous Monitoring and Cold Chain. Effective
April 1, 2016
we renamed our Continuous Monitoring and Cold Chain operating segments to Cold Chain Monitoring and Cold Chain Packaging, respectively. In addition, we transferred certain of the Cold Chain monitoring and other services to our Cold Chain Monitoring operating segment (historically included in our Cold Chain operating segment) to align with the information being used by the chief decision maker of the Company. Accordingly, all prior year segment information presented herein has been adjusted to reflect this change in our organizational structure. The following tables set forth our segment information (in thousands):
 
 
 
Year Ended March
31, 201
7
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain
Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
  $
38,635
    $
34,405
    $
12,584
    $
8,041
    $
93,665
 
                                         
Gross profit
  $
25,566
    $
21,172
    $
4,533
    $
1,968
     
53,239
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(38,943
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
14,296
 
 
 
 
Year Ended March
31, 201
6
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain
Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
  $
33,649
    $
35,692
    $
11,566
    $
3,752
    $
84,659
 
                                         
Gross profit
  $
22,205
    $
23,223
    $
4,201
    $
1,784
     
51,413
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(35,858
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
15,555
 
 
 
 
Year Ended March 31, 2015
 
 
 
Biological Indicators
 
 
Instruments
 
 
Cold Chain
Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
  $
27,390
    $
33,054
    $
10,886
    $
--
    $
71,330
 
                                         
Gross profit
  $
17,142
    $
20,763
    $
5,487
    $
--
    $
43,392
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(28,045
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
15,347
 
(
1
)
Reconciling items include general and administrative, research and development, and other expenses.
 
 
Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):
 
 
 
Year Ended March 31,
 
 
 
201
7
 
 
201
6
 
 
201
5
 
Revenues from unaffiliated customers
                       
United States
  $
52,989
    $
53,094
    $
45,798
 
Foreign
   
40,676
     
31,565
     
25,532
 
    $
93,665
    $
84,659
    $
71,330
 
 
No
foreign country exceeds
ten
percent of total revenues.
 
 
 
 
March 31,
 
 
 
2017
 
 
2016
 
Total assets
               
Biological Indicators
  $
67,233
    $
56,724
 
Instruments
   
40,805
     
49,077
 
Cold Chain Monitoring
   
35,789
     
27,613
 
Cold Chain Packaging
   
20,313
     
19,478
 
Corporate and administrative
   
7,593
     
7,856
 
    $
171,733
    $
160,748
 
 
All long-lived assets are located in the United States except for
$6,382,000
and
$20,655,000
which are associated with our French and Canadian subsidiaries, respectively.